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An enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to 
Sendai virus, a paramyxovirus, is described. The assay was found to be about 20-fold 
more sensitive than the hemagglutination inhibition assay. Differentiation between virus 
specific IgG and IgM is possible. The test appears to be especially useful in the study of 
early events in antibody formation in vivo as weil as in vitro. 
INTRODUCTION 
Viruses induce cellular and humoral immune responses in the host. This 
dichotomy is govemed by principles not yet fully understood. In cellular 
immune responses the major histocompatibility complex (MHC) is of impor-
tance at the level of T-cell differentiation (Bennink and Doherty, 1978) as 
well as of T-effector cell function (Doherty et al., 1976). The degree of MHC 
restricted antiviral responses has been shown to be under the control of 
immune response genes (Doherty et al., 1978). It is not yet known to what 
extent the antiviral antibody response is regulated by immune response 
genes. Since the induction of antibody formation against various protein 
antigens is under T-helper cell control (Roberts et al. , 1975) it is to be 
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expect.ed that regulatory functi01ls of T <'ells govprn the production of anti-
bodies as weil. 
The analysis of antibody response to viral antigens requires sensitive tests. 
Virus neutralisation assay is very sensitive (Svenag and Mandel, 1964), but it 
is too laborious to use as a routine method. Complement binding is not sen-
sitive enough. The hemagglutination inhibition assay is also not sufficiently 
sensitive and is furthermore restricted t r) antibodies to hemagglut.inin. 
Furthermore the conventional tests are not able to discriminate between dif-
ferent dasses of immunoglobulins and the antibody level is difficult to quan-
tify. 
This report describes different modifications of the enzyme-linked immu-
nosorbent assay for the detectioll of antibodies to Sendai virus. The assays 
allow the demonstration of low levels of antibodies very early after sensiti-
zation and the differentiation hetween JgG and IgM. Small differences in 
antibody levels can be detected and the sensitivity of the assays allows the 
investigation of antibodies produced by cel1s in a primary in vitro induction 
phase. 
MATERIALS AND METHODS 
Mice 
Adult male and female C3HjTIF and DBAj2 inbrpd mice (Bornholdgard, 
Ry, Denmark) were used at 8- -12 weeks of age. 
Viruses 
Sendai virus was grown in the chorioallantoic fluid of 10-day-old em-
bryonated hen eggs for 44--48 h at 37°C. 
Influenza virus A, straül Victoria, was grown in the chorioal1antoic fluid 
of ll-day-old embryonated hen eggs for 40-44 h at 37°C. 
Hemagglutination titration was carried out by Salk's pattern method 
(Salk, 1944) using 0.2% chicken red blood cells. Purification of Sendai virus 
was done by centrifugation of the virus-containing chorioallantoic fluid at 
3000 rev./min for 30 min to remove ('eIl debris and chicken red blood cells. 
The supernatant was layered on 10 ml 60% sucrose (w jv) and centrifuged for 
90 min at 20,000 X g (SW-27 rotor, Beckmann). The virus layer was col-
lected and purified by a linear sucrose gradient from 10% to 60% (wjv) cen-
trifugation for 90 min at 20,000 X g (SW-50.1 rotor, Beckmann). The visible 
virus layer was removed and dialysed against phosphate buffered saline over-
night. Aliquots of purified 01' unpurified Sendai virus were stored at -70°C. 
Protein content of the purified virus was determined by the method of 
Lowry et a1. (1951). 
Inactivation of Sendai virus was carried out by treatment with ß-propio-
lactone for 18 h at a concentration of 0.025% (Koszinowski et a1., 1977b). 
Vaccinia virus, strain WR, was propagated in Vel'o cells (monkey kidney 
cells) as de~wribed narlipl' (Ec""zinowskiflnrl Thomssen, 1975). 
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Antisera 
Sendai virus (50---100 hemagglutinating units of llupurified, ur 500 ng uf 
purified, inactivated virus) was injected intraperitoneally, intravenously, sub-
cutaneously or intranasally. Booster injections were carried out in weekly 
intervals. Mice were bled by retro-orbital puncture. Immediately before 
infection, sera were taken fur controls. 
Antisera to influenza virus were obtained by Lp. injection of 50--100 
hemagglutinating units. 
Titers of antisera to Sendai or influenza virus were determined in a hemag-
glutination inhibition assay as described earlier (Ertl and Koszinowski, 
1977). 
Vaccinia virus antisera were prepared by Lp. injection of 1 X 105 TCIDso 
vaccinia virus. Titers were measured in a complement-dependent 51Cr-release 
assay, using vaccinia virus infected L-929 cells as targets (Koszinowski et al. , 
1977a). The serum used in th:s report had a titer of 1 : 4048. 
Antiserum to rubella virus was kindly provided by Prof. R. Thomssen. 
Antisera to chorioallantoic fluid were prepared by Lp. injection of 1 ml 
chorioallantoic fluid of 12-day-old embryonated hen eggs. 
Antisera to mouse-y-globulin from rabbit (RAMjIg) were obtained from 
Behringwerke, MarburgjLahn, G.F.R. 
Antisera to mouse-IgG (RAMjIgG) and mouse-IgM (RAMjJgM) from 
rabbit were obtained from Nordic Immunological Laboratories, Tilburg, 
The N etherlands. 
Purification of [gG 
One millilitre of antiserum was dialysed for 2 h against 0.02 M phosphate 
buffer, pH 8.0, and then added to a chromatography column of 20 cm X 0.5 
cm diethylaminoethylcellulose (DEAE-Sephacel, lot No. 1482, Phannacia, 
Fine Chemicals AB, Uppsala, Sweden). IgG was eluated with 0.02 M phos-
phate bu ffer , pH 8.0. Twelve to sixteen 1 ml fractions were collected, and 
the protein content was estimated by optical density at 280 nm. The four 
peak fractions were collected and used for further assays. 
Preparation of conjugates 
Antisera and purified Sendai virus were labeled with horse radish peroxi-
dase (HRPO, Type VI, Prod. No. p-8375, Sigma Chemieal Co., St. Louis) by 
a combination of the methods of Nakane (1975) and Avrameas and Ternynk 
(1971). Briefly, 20 mg HRPO were dissolved in 1 ml of 0.3 M sodium bicar-
bonate buffer, pH 8.4. Then 0.3 ml of 25% glutaraldehyde (Serva, Heidel-
berg) was added for 30 min at room temperature. To remove excess glutar-
aldehyde the solution was applied tu a 5.0 X 1.0 Sephadex G-25 M column 
(Column PD-10, Pharmacia, Fine Chemieals, Uppsala, Sweden) in 0.3 M 
sodium bicarbonate buffer, pH 8.0. The eluated enzyme was incubated with 
0.5 ml of 0.1 M NaI04 for 30 min at room temperature. Then 0.1 ml of 
ethylene glycol was added for 10 min at room temperature. The solution was 
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applied to a Sephadex PD-10 column in 0.01 M sodium bicarbonate buffer, 
pH 9.5. The activated peroxidase was used for labeling proteins within the 
next four hours. 
Labeling of Sendai virus or antisera: 10 mg of IgG in 1 ml buffer or 4 mg 
of Sendai virus in 5 ml of 0.01 M sodium bicarbonate buffer, pH 9.5, were 
added to 20 mg of activated peroxidase. The solution was stirred for 2 h at 
room temperature. After cooling to 4°C, 5 mg solid NaBH4 were added and 
the solution left at 4°C for 2 h. The solution was then dialysed at 4°C for 
24 h. 
Purification of labeled Sendai virus from free HRPO was by 2-fold linear 
sucrose gradient (10% to 60% w/v) centrifugation for 90 min at 20,000 X g 
(SW 50.1 rotor, Beckmann). To separate conjugated IgG from free HRPO, 
the sampIes were applied to a 100 cm X 1.6 cm Biogel P-300 column in 
0.02 M Tris-HCl, 0.13 M NaCI buffer, pH 7.4. Fractions of 1 ml were col-
lected and optical density was measured at 280 nm and 403 nm. RZ values 
(A403/A280) were calculated. Fractions with RZ values of 0.5 to 0.7 were col-
lected and used in the further assays. 
Enzyme linked immunosorbent assay (ELISA) 
WeHs of flexible polyvinyl microtiter plates (M 24, Cooke Laboratory) 
were coated with 200 ng purified Sendai virus or with a 1 : 200 dilution of 
RAM/IgM suspended in a volume of 100 /-,tl, 0.02 M phosphate buffer, pH 7.4, 
for 18-24 h in a sealed humidified plastic box at 4°C. Control weHs were 
coated with chicken chorioaHantoic fluid 1 : 10 diluted in phosphate buffer 
or merely with buffer. After rinsing (3 X 2 min with 0.02 M phosphate 
buffer, pH 7.4) the weHs were filled with 150}11 normal guinea pig serum for 
2 h. After another rinsing step, 100 }11 of test serum or negative control 
serum were added and the plates left for 20-30 min at room temperature. 
Control weHs were filled with buffer instead of serum. After a further 3-fold 
rinsing, 100 }11 of conjugate containing 50-200 ng of SV-HRPO or 100 ng of 
labeled anti-mouse--y-globulin IgG (RAM/Ig, RAM/IgG or RAM/IgM) diluted 
in buffer containing 2% BSA, were incubated for 20-30 min at room tem-
perature. After 3-fold rinsing 100 /-11 of freshly prepared substrate (ortho-
phenylenediamine 0.4 mg/mI + 0.006% H20 2 in 0.1 M citrate buffer, pH 5.0) 
was added and the plates incubated in the dark at room temperature. After 
30 min, 50 /-11 2 M sulfuric acid were added to each weH to stop the enzyme 
reaction and the absorbance was measured at 493 nm. A solution of 100/-11 
of substrate and 50 /-LI of sulfuric acid was taken as blank. Absorbance was 
measured in disposable cuvettes, 1 to 2.5 diluted in 5% Na2S04. The experi-
mental schedule is shown in Fig. 1. 
Primary induction of antibody formation in vitro 
1 X 108 viable spleen lymphocytes/ml of DBA/2 mice were cultured in 
25 ml RPMI 1640 medium (Grand Island Biological Co., N.Y.) supplemented 
with 10% FCS (fetal calf serum), antibiotics, 2 X 10-5 M 2-mercaptoethanol 
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EXPERIMENTAL SCHEDULE 
\y y y y I I.Coating 
I 
I. Test serum 
11. Conjugate 
o Sendai virus Y RAM IlgM 
V test serum 
eSV-HRPO "RAM/lg-HRPO 
Fig. 1. Principle of different ELISA techniques. I. Coating with SV or RAM/IgM (18-
24 h). 11. After 3-fold rinsing, normal guinea pig serum was incubated in the weHs for 2 h 
and rinsed out. The test serum was then added and incubated at RT for 20-30 min. 
111. After 3-fold rinsing SV-HRPO or enzyme-Iabeled RAM/Ig, RAM/IgG or RAM/IgM 
was added for 20-30 min. Orthiphenylenediamine and H2 0 2 were used as substrate. 
and 1% glutamine with 100 ng ß-propiolactone inactivated Sendai virus/mI 
for 4 days at 37°C in a humidified atmosphere with 5% CO 2 • After 3-fold 
washings the cells were resuspended in aserum free medium for another 
2 days. Control cells were cultured under the same conditions in a virus free 
medium. Supematants were coHected and freeze-dried. 
RESULTS 
Test requirements 
Coating conditions. The sensitivity of ELISA depends on the concentra-
tion of Sendai virus or RAM/IgM used for coating of wells (Fig. 2). High con-
centrations of antigen and a 10-2 to 10-3 dilution of RAM/IgM were found 
to give best results. For further assays 200 ng SV/weH or a 1 : 200 dilution 
of RAM/IgM were used. 
Coating procedure of SV or RAM/IgM is time-dependent. Maximal values 
of specific bin ding were obtained if the assay was done about 24 h after 
coating of weHs with SV or RAM/IgM. Coating for a time exceeding 48 h 
resulted in loss of activity probably due to antigen degradation in the case of 
virus or to a loss of binding of proteins to the plastic weHs. 
Coating procedure is independent from temperature. WeHs coated with SV 
or RAM/lgM at 4°C, 22°C or 37°C showed nearly identical results. To 
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Fig. 2. Coating concentration of SV or RAM/IgM. WeHs were coated with different con-
centrations of SV (A) or RAM/IgM (B). (e---e) serum of DBA/2 mice, 1 week after 
infection with 100 HAU SV (serum No. 13.1); (0---0) Pre-infection serum (serum 
No. 13.0). Sera were used at a dilution of 1 : 100. SV-HRPO was used as enzyme-labeled 
reagent. 
prevent bacterial contamination of the weHs and to decrease the degradation 
of the temperature-sensitive viral antigens, weHs were incubated at 4°C. 
Within the range pH 5.0 to pH 9.0 there was no major difference in the coat-
ing capacity of SV or RAMjIgM. Results with weHs coated at neutral pH 
were slightly superior to those with weHs coated at basic or acid pH. There-
fore weHs were usually coated in 0.02 M phosphate buffer, pH 7.4. 
Antibody binding conditions. Immunoglobulins have a high affinity for 
plastic surfaces. Thus after the coating procedure weHs were incubated with 
a 20% solution of guinea pig serum, which did not react with SV, mouse 
immunoglobulins or anti-mouse-immunoglobulin sera. This step is necessary 
to block non-specific adsorption of antibodies to the weHs. Non-specific 
adsorption of antibodies to plastic weHs is much slower than specific binding 
to a solid phase reagent. Binding of SV-antibodies to untreated weHs is 
almost undetectable after 20 min, whereas specific binding to SV-coated 
weHs is complete after this time. The non-specific adsorption of mouse-
immunoglobulin to SV-coated and untreated weHs in comparison to specific 
binding of SV-antibodies is shown in Fig. 3. Coating weHs with SV seems to 
inhibit the unspecific adsorption of IgG but not of IgM. The ratio of specific 
to unspecific binding is optimal after an incubation period of 20 min for the 
test serum. 
Optimal conditions for specific binding of enzyme-labeled reagents. For 
the detection of Sendai virus antibodies of aH immunoglobulin classes, we 
used HRPO-labeled SV. To differentiate murine IgG from IgM antibodies 
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Fig. 3. Kinetics of specific and non-specific binding of mouse immunoglobulin. WeHs were 
coated with SV or buffer. Incubation of antisera was stopped after different intervals. 
(e e) anti-SV serum No. 13.1 (1 : 100), incubated in weHs coated with SV; 
( ... ---... ) pre-infection serum No. 13.0 (1 : 100), incubated in weHs coated with SV; 
(. .) anti-SV serum No. 13.1 (1 : 100), incubated in weHs treated with buffer. 
HRPO-Iabeled RAM/Ig (A), RAM/IgG (B) and RAM/IgM (e) were used as conjugate. 
HRPO-Iabeled rabbit anti-mouse-immunoglobulin sera were used. After the 
conjugation procedure the unbound HRPO had to be removed carefully by 
ultracentrifugation or gel chromatography as free HRPO tends to adopt non-
specifically to the wells. One of the main problems of antibody detection by 
radioimmunoassay is non-specific adsorption of 12sI-Iabeled antibodies or 
antigen to the test weHs. Surprisingly, with HRPO-labeled antibodies or anti! 
gens non-specific bin ding is much slower than with unlabeled or 12sI-Iabeled 
proteins. By use of a short incubation time (20-30 min) non-specific stain-
ing of negative controls may be completely avoided. After 60 min non-
specific binding of conjugates increases rapidly. The intensity of staining 
with positive sera depends on the concentration of conjugate added to the 
wells. High concentrations of enzyme-labeled SV or RAMjIg give strong 
staining of positive wells after addition of substrate, but unfortunately also 
causes staining of negative controls, so that weak antibodies or antibodies at 
high dilutions are no longer distinguishable from negative controls. 50-100 
ng SV-HRPO or 100 ng enzyme-Iabeled RAMjIg (RAMjIgG or RAMjIgM) 
gave sufficient staining of positive wells (A > 0.5) and optimal ratios of spe-
cific to unspecific binding (>50). 
Specificity of the assay. Virus grown in the chorioallantoic cavity of 
embryonated chicken eggs contains the carbohydrate moiety derived from 
the host cell (White, 1974). Antibody formation was studied in mice 
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Fig. 4. Blocking of ChHC antibodies. WeHs were coated at solid phase with SV (A) or a 
1 : 10 dilution of CF (B). Antisera were added for 30 min at room temperature. (+) SV 
antiserum No. 13.1; (e) Influenza virus antiserum; ("') preserum No. 13.0. (Pre-infection 
serum showed no activity and is omitted for the sake of clarity.) After 3-fold rinsing weHs 
were treated for 2 h with buffer (---), or CF (1 : 5) (- - - - - -). SV-HRPO was used as 
conjugate. 
infected with egg-grown virus and the same virus was used, after purification, 
for coating or also for conjugation. Therefore this assay detects not only 
Sendai virus antibodies but also antibodies directed against chicken host 
components (ChHC). By this mechanis, high crossreactivity with sera 
directed against other egg-grown viruses such as influenza is found. Sera 
from virus-primed mice bind to wells coated either with Sendai virus or 
ChHC (Fig.4). By addition of excess chorioallantoic fluid, antibodies 
directed against ChHC are saturated and are no longer stained by SV-HRPO 
as is shown by negative results with wells coated with ChHC (Fig. 4B) while 
specific binding for viral antigen remains positive (Fig. 4A). The activity of 
Sendai virus antisera was reduced by 25% to 30%, indicating that 25% to 
30% of the antibodies are directed against ChHC. A similar percentage is 
found after sensitizing mice to influenza virus A (Gerhard et al., 1975). The 
percentage of antibody directed against ChHC depends on the virus prepara-
tion used for sensitization and on the application route. Injection of large 
amounts of inactivated virus results in a higher fraction of ChHC antibodies 
than infection with a small amount of infective virus. Antisera produced by 
intranasal infection show no crossreactivity with ChHC (data not shown). 
The blocking of anti-ChHC specificity of bound antibodies with chorioallan-
toic fluid is only effective when SV-HRPO is used as the labeled reagent. In 
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Fig. 5. Sensitivity of different test procedures for the measurement of SV antibodies. 
WeHs were coated with SV, with exception of procedure All, for which RAM/IgM was 
used. Dilutions of SV antiserum No. 13.1 (e) and corresponding pre-infection serum (e) 
were added for 30 min at room temperature. SV·HRPO was the labeled reagent for figure 
A. In figure B HRPO labeled antibodies against immunoglobulins were used (Ill RAM/Ig, 
IV RAM/IgG, V RAM/IgM). 
assays where enzyme-Iabeled RAM/Ig preparations were used, test sera were 
routinely preabsorbed three times for 15 min at room temperature on weHs 
coated with chorioallantoic fluid. 
Crossreactivities with sera directed to other viruses such as rubella or 
vaccinia were not observed (data not shown). 
Sensitivity of the assay. A SV-hyperimmune serum was titrated by several 
modifications of ELISA as shown in Fig. 5. For demonstration of the total 
amount of SV antibodies two methods were used. Curve I shows the results 
with wells coated with SV and SV-HRPO as enzyme-Iabeled reagent, while in 
curve 111 enzyme-Iabeled RAM/Ig was used. Both methods are equivalent in 
sensitivity, detecting SV antibodies (serum No. 13.2) to a dilution of ab out 
1 : 75.000. The serum has a titer of 1 : 2560 in HIA. 
Two methods were used to demonstrate IgM antibodies. In the first, wells 
were coated with RAM/IgM (Fig. 5, curve 11), total IgM was then bound to 
the solid phase and SV specific IgM was detected by SV-HRPO. In the 
second procedure (Fig. 5, curve V) SV was used as solid phase reagent, SV 
antibodies were bound irrespective of Ig cIass and demonstration of IgM was 
by enzyme-Iabeled RAM/Igl\ll. The first procedure was superior in sensitivity 
to the second. Selective determination of anti-SV IgG was done by enzyme-
labeled RAM/IgG (Fig. 5, curve IV). 
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High concentrations of preinfection serum were non-specifically stained 
especially if RAM/IgG was used as enzyme reagent. 
In our experiment (Fig. 5) we used an antiserum from DBA/2 mice, which 
was produced by three injections of 100 HAU of SV at weekly intervals. 
Mice were bled one week after the last injection. 
Application of the assay 
Early antibody synthesis. Infection of mice with 100 HAU of Sendai virus 
using different application routes (intraperitoneal, intravenous, intranasal or 
subcutaneous) resulted in all cases in good antibody production after 2 to 
4 days (Fig. 6). Infection by Lp., Ln. or s.c. injection gave comparable 
amounts and time courses of antibody production, while after i.v. infection 
antibodies increased earlier and reached, especially in the case of IgM, higher 
levels. HIA gave low, if any, demonstrable titers during the first week. 
Propagation of SV in mice is not necessary to provide powerful stimulus 
for antibody production. Lp. injection of a high dose of ß-propiolactone 
SVs.c. SVi.n. 
05 
'00 SV inactivated 
0.5 ::J 
~ 
100 
14 
SVi.p. SV · ,1\, t.V. I , 
I \ ./~~, 
'00 '/ ~ 
(l· 
I I 
1/ 
'. / \ 
'" 
0.5 05 
100 
0246814 02468 14 
days after infection days after infection 
Fig. 6. Influence of application route on antibody formation: Sera, which were pooled 
from three mice, were obtained at different intervals after Lp., Lv., s.c. and Ln. injection 
of SV and tested in a dilution of 1 : 100. Total SV antibody (e e) was demon-
strated by procedure I (Fig. 5), SV-IgM (e- - - - - -e) by procedure 11 and SV-IgG by pro-
cedure IV (e---e). Titers in HIA were also determined (e e). 
Fig. 7. Antibody formation after Lp. injection of inactivated SV: See legend of Fig. 6. 
Serum was obtained after Lp. injection of 500 ng of ß-propiolactone inactivated SV. 
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inactivated virus (0.5 j.1g/mouse) caused antibody production on a similar 
scale to that after injection of infective virus (Fig. 7). Production of specific 
IgM was if anything slightly increased. 
Antibody production in vitro. In the Sendai virus system it is possible to 
stimulate cytolytic T-Iymphocytes in a primary in vitro induction phase 
(Koszinowski, unpublished results). It was not known whether specific anti-
bodies are also produced in these cultures. Freeze-dried supernatants (25 ml) 
of primary induction phase cultures were collected and diluted in 1 ml 
0.02 M phosphate buffer, pH 7.4. Total Sendai virus antibodies and IgM 
antibodies against SV were determined. As seen in Fig. 8, spleen lympho-
cytes cultured in the presence of SV produced antibodies to SV. In compari-
son with the in vivo production of Sendai virus antibodies by DBA/2 mice in 
one week (Fig. 8B), antibody content of the in vitro cultures was rather low. 
This may be due to the formation of immune complexes with the large 
amount of Sendai virus (2.5 j.1g) per culture or to the short duration of anti-
body production (2 days after rem oval of medium, containing fetal calf 
serum). 
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Fig. 8. A: titration of SY-antibodies produced in vitro. Total SY-antibody (---) or 
SY-IgM (- - -) were determined in supernatants of DBA/2lymphocytes previously cul-
tured in the presence (.) or absence (e) of SV. B: titration of SY-antibodies in the serum 
of DBA/2 mice one week after infection with SY (.) and test results for the correspond-
ing pre-infection serum (e). 
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DISCUSSION 
This report describes an enzyme-linked immunosorbent assay (ELISA) for 
the demonstration of Sendai virus antibodies. The main advantages of ELISA 
are greater sensitivity in comparison with standard assays and the possibility 
of differentiating between immunoglobulins of the IgG and IgM c1ass 
(Leinikki and Passila, 1977). In routine procedures antibodies to paramyxo-
viruses are determined by hemagglutination inhibition assay or by comple-
ment fixation. Titers demonstrable by these methods rarely exceed 1 : 200-
1 : 500 and often change from one test to the next. Ta prove a primary 
infection IgG and IgM have to be separated by ultracentrifugation. 
The enzyme-linked immunosorbent assay is about 20-fold more sensitive 
than the hemagglutination inhibition assay; it detects other (and more) anti-
genic determinants, and it is not influenced by non-specific inhibitors wh ich 
often confuse the results of HIA. Virus neutralisation tests are very sensitive 
and detect low levels of antibodies at an early stage of infection (Svenag and 
Mandel, 1964) but are too laborious for routine work, while results are often 
non-specific because of the influence of interferon. The sensitivity of ELISA 
is comparable with that of RIA (Ertl, unpublished results). ELISA has 
several advantages over RIA. The chloramine T method genetically used 
(Hunter and Greenwood, 1962) causes chemical damage to the antigens of 
the Sendai virus; for example, hemagglutinin activity is totally destroyed. 
Enzyme-Iabeling of the virus is more gentle and hemagglutinin activity is 
only slightly reduced. Also, enzyme conjugates are more stable than 
iodinated proteins. Other advantages c1aimed for such forms of non-radio-
active labeled tracers are the absence of health hazard associated with the 
labeling procedure and work with radioactive products, and the low cost of 
both the enzyme required for labeling and the colorimetric equipment used 
for detection. Estimates of antibody titer can be even made visually. For 
labeling of antigen and anti-mouse immunoglobulins, horseradish peroxidase 
was used, because it has the advantages of being easily detectable with high 
sensitivity by various substrates and also of being very stable. 
Peroxidase may be coupled to proteins by bifunctional reagents such as 
glutaraldehyde. This is simple to perfarm but requires availability of amino 
and/or hydroxyl groups on both the peroxidase and the protein. In many 
peroxidase preparations a majority of these groups is blocked by allythio-
cyanate (Ornstein, 1966) so that only a low proportion of reaction sites is 
available for coupling. 
An alternative method of coupling peroxidase to protein is oxidation of 
the glycoside portion of the enzyme by periodate to form aldehyde groups 
able to bind to the amino groups of the pro tein (Nakane, 1975). Unfortu-
nately some peroxidase preparations contain only low amounts of carbo-
hydrates which are necessary for this coupling procedure. In this report a 
combination of both labeling procedures is used which was found to be 
highly reliable and reproducible. Final treatment with sodium borohydride 
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stabilizes the linkages of glutaraldehyde and glycoside-derived aldehydes to 
the amino groups. 
Five ways of assessing antibodies to Sendai virus are described. The total 
amount of SV antibodies bound to surface coated SV antigens is demon-
strable either by using enzyme-Iabeled SV or altematively by the application 
of enzyme-Iabeled rabbit anti-mouse Ig. The use of SV-HRPO has the advan-
tage of being applicable for testing SV-antibodies from different species. The 
use of enzyme-Iabeled anti-mouse Ig is restricted to one animal species, but 
one HRPO-Iabeled reagent can be used for detection of antibodies to various 
viruses on weHs coated with the corresponding antigens. This method has a 
certain risk of increased non-specific activity but this can be avoided by use 
of short incubation times. 
Differentiation of immunoglobulin classes is possible by the demonstra-
tion of SV specific antibodies bound to SV coated weHs with an Ig class 
specific conjugate. However, for the measurement of virus specific IgM the 
coating of weHs with RAMjIgM and quantification with enzyme-Iabeled SV 
was found to be superior. The amount of IgM in the serum is much sm aller 
than that of IgG, but the percentage of specific IgM is higher than that of 
IgG at the early phase of immune reaction. Much of the IgM fixed by anti-
IgM serum to the solid phase should therefore bind SV-HRPO. On the other 
hand, if SV is coated, binding of specific IgM to SV is competitively inhibited 
by specific IgG so that the amount of IgM detectable by enzyme-Iabeled 
anti-IgM is reduced. 
In the ELISA test it is desirable to have a highly purified antigen and a 
system whereby specific binding of the test antibody can be distinguished 
from non-specific adherence phenomena. Since paramyxoviruses grown in 
embryonated eggs contain chicken host components even after purification 
it is particularly important to determine antibodies with specificities for 
ehHe. Using wells coated with ehHe we were able to distinguish between 
antiviral and anti-eh He activity of the sera. Anti-ehHe activity, which 
amounted to about 30% of total antibody activity, could be easily removed 
by eompetition with chorioallantoic fluid or by preadsorption of test sera on 
wells eoated with ehorioallantoic fluid. Although it is possible to use viral 
antigens grown in cell cultures in this test (data not shown) the requirement 
for speeifieity ean be easily fulfilled by egg grown virus. With little effort the 
assay system ean be modified for investigation of antibodies to a particular 
protein of the virus using purified viral pro teins, for example a purified 
hemagglutinin or a fusion faetor, which could be used as coating material or 
as the peroxidase labeled conjugate. 
The main advantage of the assay is its ability to detect low levels of spe-
cific IgG or IgM antibodies. After infection of mice by different routes, the 
kinetics of IgG and IgM antibody formation were studied. Antibody produc-
tion after inoculation of virus by the i.p., s.c. or i.n. routes showed similar 
kinetics, while infection by the i.v. route caused earlier on set of antibody 
formation and higher IgM levels. Sensitization with ß-propiolactone inacti-
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vated SV showed similar results with enhanced IgM production. It is not yet 
dear which mechanisms are responsible for these differences. Data obtained 
with the HIA indicate that this test is too insensitive to study early events in 
antibody formation. 
We were able to demonstrate specific antibody formation in the super-
natants of cell cultures after 6 days of primary sensitization of lymphocytes 
with viral antigens in vitro. These antibodies were not demonstrable by HIA 
at all. In a similar way the assay should help in selecting viral antibody pro-
ducing hybrid omas at an early stage. Use of this assay for analysis of cellular 
and viral requirements for induction and regulation of antibody formation is 
in progress. 
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